Search research articles
Contact Us
Filters
Showing results (101-110 of 134) with videos related to
Page
of 14
Sort By:
Scientific Reports
|
May 21, 2021
Metabolomics and computational analysis of the role of monoamine oxidase activity in delirium and SARS-COV-2 infection
Miroslava Cuperlovic-Culf, Emma L Cunningham, Hossen Teimoorinia, et al.
Neurobiology of Aging
|
December 11, 2007
TNFR-associated factor-2 (TRAF-2) in Alzheimer's disease
Doris Culpan, Dougal Cram, Kate Chalmers, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
December 27, 2022
A qualitative study to inform adaptations to a brain health intervention for older adults with type 2 diabetes living in rural regions of Ireland
Claire T McEvoy, Joanne Regan-Moriarty, Catherine Dolan, et al.
Neurology
|
May 3, 2015
Etanercept in Alzheimer disease: A randomized, placebo-controlled, double-blind, phase 2 trial
Joseph Butchart, Laura Brook, Vivienne Hopkins, et al.
Cells
|
October 23, 2021
Lipid Profiling of Alzheimer's Disease Brain Highlights Enrichment in Glycerol(phospho)lipid, and Sphingolipid Metabolism
Sumeyya Akyol, Zafer Ugur, Ali Yilmaz, et al.
Trials
|
November 8, 2015
Baseline characteristics, analysis plan and report on feasibility for the Prevention Of Decline in Cognition After Stroke Trial (PODCAST)
Polly Scutt, Dan Blackburn, Kailash Krishnan, et al.
Journal of Psychopharmacology (Oxford, England)
|
January 21, 2017
Clinical practice with anti-dementia drugs: A revised (third) consensus statement from the British Association for Psychopharmacology
John T O'Brien, Clive Holmes, Matthew Jones, et al.
Trials
|
November 26, 2013
Prevention of Decline in Cognition after Stroke Trial (PODCAST): a study protocol for a factorial randomised controlled trial of intensive versus guideline lowering of blood pressure and lipids
Daniel J Blackburn, Kailash Krishnan, Lydia Fox, et al.
Plos One
|
January 18, 2017
Intensive versus Guideline Blood Pressure and Lipid Lowering in Patients with Previous Stroke: Main Results from the Pilot 'Prevention of Decline in Cognition after Stroke Trial' (PODCAST) Randomised Controlled Trial
Philip M Bath, Polly Scutt, Daniel J Blackburn, et al.
Communications Biology
|
November 23, 2022
Dementia with Lewy bodies post-mortem brains reveal differentially methylated CpG sites with biomarker potential
Xiaojian Shao, Sangeetha Vishweswaraiah, Miroslava Čuperlović-Culf, et al.
Page
of 14
Search research articles
Search
Showing results (101-110 of 134) with videos related to
Sort By:
Page
of 14
Scientific Reports
|
May 21, 2021
Metabolomics and computational analysis of the role of monoamine oxidase activity in delirium and SARS-COV-2 infection
Miroslava Cuperlovic-Culf, Emma L Cunningham, Hossen Teimoorinia, et al.
Neurobiology of Aging
|
December 11, 2007
TNFR-associated factor-2 (TRAF-2) in Alzheimer's disease
Doris Culpan, Dougal Cram, Kate Chalmers, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
December 27, 2022
A qualitative study to inform adaptations to a brain health intervention for older adults with type 2 diabetes living in rural regions of Ireland
Claire T McEvoy, Joanne Regan-Moriarty, Catherine Dolan, et al.
Neurology
|
May 3, 2015
Etanercept in Alzheimer disease: A randomized, placebo-controlled, double-blind, phase 2 trial
Joseph Butchart, Laura Brook, Vivienne Hopkins, et al.
Cells
|
October 23, 2021
Lipid Profiling of Alzheimer's Disease Brain Highlights Enrichment in Glycerol(phospho)lipid, and Sphingolipid Metabolism
Sumeyya Akyol, Zafer Ugur, Ali Yilmaz, et al.
Trials
|
November 8, 2015
Baseline characteristics, analysis plan and report on feasibility for the Prevention Of Decline in Cognition After Stroke Trial (PODCAST)
Polly Scutt, Dan Blackburn, Kailash Krishnan, et al.
Journal of Psychopharmacology (Oxford, England)
|
January 21, 2017
Clinical practice with anti-dementia drugs: A revised (third) consensus statement from the British Association for Psychopharmacology
John T O'Brien, Clive Holmes, Matthew Jones, et al.
Trials
|
November 26, 2013
Prevention of Decline in Cognition after Stroke Trial (PODCAST): a study protocol for a factorial randomised controlled trial of intensive versus guideline lowering of blood pressure and lipids
Daniel J Blackburn, Kailash Krishnan, Lydia Fox, et al.
Plos One
|
January 18, 2017
Intensive versus Guideline Blood Pressure and Lipid Lowering in Patients with Previous Stroke: Main Results from the Pilot 'Prevention of Decline in Cognition after Stroke Trial' (PODCAST) Randomised Controlled Trial
Philip M Bath, Polly Scutt, Daniel J Blackburn, et al.
Communications Biology
|
November 23, 2022
Dementia with Lewy bodies post-mortem brains reveal differentially methylated CpG sites with biomarker potential
Xiaojian Shao, Sangeetha Vishweswaraiah, Miroslava Čuperlović-Culf, et al.
Page
of 14